Anthem Biosciences Limited (BOM:544449)
India · Delayed Price · Currency is INR 871.50
-3.10 (-0.35%)
At close: Aug 21, 2026
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 490.8 billion as of August 21, 2026. Its market cap has increased by 3.93% in one year.
Market Cap
490.80B
Enterprise Value
481.95B
Revenue
20.07B
Ranking
n/a
PE Ratio
85.22
Stock Price
871.50
ChartMarket Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 490.80B, an increase of 19.66%. That is a compound annual growth rate of 17.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 490.80B | 34.14% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Linde India | 569.19B |
| Abbott India | 557.70B |
| Hindustan Copper | 553.72B |
| KEI Industries | 528.68B |
| Colgate-Palmolive (India) | 514.04B |
| GlaxoSmithKline Pharmaceuticals | 491.21B |
| UPL Limited | 480.84B |
| Authum Investment & Infrastructure | 469.45B |